Raquel Olmos Gómez
Yecla, Murcia, 30510, Spain
NCT Number: NCT04329793
The improvement of walking capacity is a key objective of the rehabilitation of children with PC. There are different approaches from physiotherapy to address this need, including walking on the ground and on treadmill with partial weight support. Currently, there are robotic technologies adapted to the functional rehabilitation of patients. Assisted gait training with robotic devices such as the Walkbot allows a longer duration of training, at more variable speeds, and with a constant gait pattern adapted to the patient. This training, based on the intensity and repetition of the movement, has beneficial effects on the recovery and improvement of the patient's postural and locomotor functions.
There are some studies that evaluate walking interventions on treadmill with partial weight support, on the ground and in assisted walking robot in patients with PC.
Currently, there are no studies conducted that report the effectiveness of interventions performed with robotic walking training device Walkbot K on PC. However, studies in adults with Walkbot S, affected with neurological injury, have reported good results.
Assisted gait training with robotic devices such as the Walkbot, based on the intensity and repetition of the movement, has beneficial effects on the recovery and improvement of the patient's postural and locomotor functions. However, due to the little evidence that exists, it is necessary to know the effectiveness of the Walkbot assisted walking robot in these patients by means of a clinical trial that allows to firmly establish the scope of its benefits.
Looking for future studies?
Notify Me3 year–17 year
All sexes
Interventional
Not applicable
Yecla, Murcia, 30510, Spain
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The experimental group will receive at least 3 treatment sessions per week consisting of 40 minutes in robot-assisted gait training with Walkbot System in addition to their usual Physical therapy sessions. In total, the number of Walkbot sessions will be 20, in uninterrupted weeks.
Other names: Physical Therapy
The control group will receive their usual Physical therapy sessions during 6 weeks.
Time frame: Baseline, immediately after the intervention, 1 month after the intervention, 3 months after the intervention
Changes in Gross Motor Function Measure-88 (dimensions IV y V)
Time frame: Baseline, immediately after the intervention, 1 month after the intervention, 3 months after the intervention
Differences in the basic activities of daily life, measured with the PedsQL- Cerebral Palsy Module
Time frame: Baseline, immediately after the intervention, 1 month after the intervention, 3 months after the intervention
Differences in muscle strength of lower limbs, measured with dynamometer.
Time frame: Baseline, immediately after the intervention, 1 month after the intervention, 3 months after the intervention
Analyze if the range of joint mobility is increased in those joints that are more limited, measured with goniometer.
Time frame: Baseline, immediately after the intervention, 1 month after the intervention, 3 months after the intervention
Changes in spasticity values, measured with the modified Ashworth Scale. Higher scores mean worse outcome. Minimum value is 0. Maximum value is 4.
Time frame: Baseline, immediately after the intervention, 1 month after the intervention, 3 months after the intervention
Changes in Edinburgh Visual Gait Scale values. Higher scores mean worse outcome. Minimum value is 0. Maximum value is 34.
Time frame: Baseline, immediately after the intervention, 1 month after the intervention, 3 months after the intervention
Changes in 6 minutes walk test
Universidad de Murcia
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07729800
Brain Damage, Chronic, Brain Diseases
Lahore, Pakistan
View Trial DetailsNCT07683338
Bilateral Spastic Cerebral Palsy, Brain Damage, Chronic
Faisalabad, Punjab Province, Pakistan
View Trial DetailsNCT07706517
Brain Damage, Chronic, Brain Diseases
Saint-Etienne, France
View Trial DetailsNCT05791877
Brain Damage, Chronic, Brain Diseases
Wilmington, Delaware, United States
View Trial Details